

Crosslay Remedies Profile
Key Indicators
- Authorised Capital ₹ 157.00 Cr
- Paid Up Capital ₹ 143.19 Cr
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 250.00 Cr
- Satisfied Charges ₹ 983.96 Cr
- Revenue Growth 16.13%
- Profit Growth 40.61%
- Ebitda 23.90%
- Net Worth 58.71%
- Total Assets 31.76%
About Crosslay Remedies
Crosslay Remedies Limited (CRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 January 2002 and has a history of 23 years and three months. Its registered office is in Delhi, India.
The Corporate was formerly known as Crosslay Remedies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 157.00 Cr and a paid-up capital of Rs 143.19 Cr.
The company currently has active open charges totaling ₹250.00 Cr. The company has closed loans amounting to ₹983.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Crosslay Remedies Limited India are Gaurav as COMPANY SECRETARY and Umang Jaiswal as Cfo. Vandana Pakle, Anas Wajid, Mradul Kaushik, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U24239DL2002PLC113719
- Company No.
113719
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2002
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Crosslay Remedies?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gaurav | Company Secretary | 02-Feb-2023 | Current |
Umang Jaiswal | CFO | 02-Feb-2023 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vandana Pakle ![]() | Director | 04-Feb-2020 | Current |
Anas Wajid ![]() | Director | 01-Jan-2019 | Current |
Mradul Kaushik ![]() | Director | 18-Oct-2019 | Current |
Yogesh Sareen ![]() | Director | 10-Jul-2015 | Current |
Financial Performance of Crosslay Remedies.
Crosslay Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.13% increase. The company also saw a substantial improvement in profitability, with a 40.61% increase in profit. The company's net worth Soared by an impressive increase of 58.71%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Crosslay Remedies?
In 2023, Crosslay Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Eqova Healthcare Private Limited
Vandana Pakle and Yogesh Sareen are mutual person
- Jaypee Healthcare Limited
Vandana Pakle, Mradul Kaushik and 1 more are mutual person
- Radiant Life Care Foundation
Vandana Pakle and Mradul Kaushik are mutual person
- Max Hospitals And Allied Services Limited
Vandana Pakle and Mradul Kaushik are mutual person
- Hometrail Buildtech Private Limited
Anas Wajid and Yogesh Sareen are mutual person
Charges (Loans)
₹250.00 Cr
₹983.96 Cr
Charges Breakdown by Lending Institutions
- Others : 250.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
25 Dec 2020 | Others | ₹200.00 Cr | Open |
23 Dec 2020 | Others | ₹50.00 Cr | Open |
20 Nov 2018 | Axis Bank Limited | ₹75.00 Cr | Satisfied |
24 Feb 2016 | Others | ₹180.00 Cr | Satisfied |
31 Mar 2015 | Punjab National Bank | ₹2.50 Cr | Satisfied |
How Many Employees Work at Crosslay Remedies?
Crosslay Remedies has a workforce of 1434 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Crosslay Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crosslay Remedies's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Crosslay Remedies
Recent activity within the organization
- Annual General Meeting
Crosslay Remedies Limited last Annual general meeting of members was held on 29 Aug 2024 as per latest MCA records.
- Balance Sheet
Crosslay Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others of Rs. 50.00 Cr registered on 23 Dec 2020 with Charge ID 100405347 was modified on 05 Feb 2024.
- Director Appointment
Gaurav was appointed as a Company Secretary was appointed as a Company Secretary on 02 Feb 2023 & has been associated with this company since 2 years 2 months .
- Charges
A charge with Others of Rs. 200.00 Cr registered on 25 Dec 2020 with Charge ID 100405633 was modified on 14 Feb 2022.
- Charges
A charge registered on 20 Nov 2018 via Charge ID 100221293 with Axis Bank Limited was fully satisfied on 09 Apr 2021.
Recent News, Updates & Announcement
- Max Healthcare Q3 results: Net profit rises 26% to ₹338 crore | Mint.
Max Healthcare Institute Ltd on Wednesday reported a 26% growth in its profit after tax at ₹338 crore in the December quarter. The company posted a Profit After Tax (PAT) of ₹269 crore in the third quarter of FY23.
- Max Healthcare Institute acquires further stake in Eqova Healthcare.
The company completed the acquisition of additional 34,000 equity shares having a face value of Rs 10 each fully paid up of Eqova Max Healthcare Institute had earlier entered into a share purchase ag.
Frequently asked questions
What is the Incorporation or founding date of Crosslay Remedies Limited?
Crosslay Remedies Limited was incorporated on 08 Jan 2002.
What is authorized share capital and paid-up capital of Crosslay Remedies Limited?
The authorized share capital of Crosslay Remedies Limited is ₹ 157.00 Cr and paid-up capital is ₹ 143.19 Cr.
Who are the current board members & directors of Crosslay Remedies Limited?
Currently 6 directors are associated with Crosslay Remedies Limited.
- Vandana Ramesh Pakle
- Gaurav
- Umang Jaiswal
- Anas Abdul Wajid
- Mradul Kaushik
- Yogesh Kumar Sareen
What is the registered address of Crosslay Remedies Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Crosslay Remedies Limited is N-110, Panchsheel Park India, New Delhi, 110017.
What is the corporate identification number (CIN) and company number of Crosslay Remedies Limited?
The corporate identification number (CIN) of Crosslay Remedies Limited is U24239DL2002PLC113719 and the company number is 113719 as per Ministry of Corporate Affairs (MCA).
What is the official website of Crosslay Remedies Limited?
The Official website of Crosslay Remedies Limited is https://www.maxhealthcare.in
What has been the recent revenue trend for Crosslay Remedies Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Crosslay Remedies Limited has risen by 16.13%.
How many employees does Crosslay Remedies Limited currently have?
As Per 2023 financial reports, 1434 employees are currently employed by Crosslay Remedies Limited.
What change has been observed in the net worth of Crosslay Remedies Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Crosslay Remedies Limited has experienced an upsurge of 58.71%.
What are the total open charges for Crosslay Remedies Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Crosslay Remedies Limited amount to ₹ 250.00 Cr.
When was the last Balance Sheet of Crosslay Remedies Limited filed with the ROC?
The most recent Balance Sheet for Crosslay Remedies Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Rohit KapoorDirector
- Rakesh PrustiDirector
- Garima AggarwalWholetime Director
- Ganesh ManiWholetime Director
- Girdhar GyaniDirector
- Vinay AgarwalDirector
- Shubnum SinghDirector
- Gaurav AggarwalWholetime Director
Similar Companies Based on Hospitals
- Manipal Health Enterprises Private Limited Bangaluru, Karnataka, India
- Manipal Hospitals Private Limited Bangaluru, Karnataka, India
- Aster Dm Healthcare Limited Bangaluru, Karnataka, India
- Global Health Limited South Delhi, Delhi, India
- Fortis Healthcare Limited Rupnagar, Punjab, India
- Asian Institute Of Gastroenterology Private Limited Hyderabad, Telangana, India
- Wockhardt Limited Aurangabad, Maharashtra, India